W. Alberto Sifuentes Giraldo: An Overview of Thrombotic Risk and Diagnostic Criteria in Antiphospholipid Syndrome
W. Alberto Sifuentes Giraldo, Rheumatologist at Hospital Nuestra Señora de Sonsoles (Sacyl), shared a post on X:
“Antiphospholipid Syndrome
Rare systemic autoimmune disease (prevalence: 50 per 100,000 in females and 9.8 per 100,000 in males) responsible for thrombotic events and obstetric morbidity in individuals with persistent antiphospholipid autoantibodies:
- anticardiolipin antibodies IgG or IgM
- anti-β2-glycoprotein-I antibodies IgG or IgM
- lupus anticoagulants
It is a leading cause of acquired thrombophilia, accounting for 10 percent of arterial or venous thrombosis.
These thrombotic events can lead to acute organ dysfunction or failure, sometimes requiring intensive care unit admission, or can even escalate into a ‘thrombotic storm’ called the catastrophic antiphospholipid syndrome.
Classification criteria for antiphospholipid syndrome have very been updated in 2023 by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR).
These criteria are applicable to patients with at least one positive laboratory test within 3 years of a clinical manifestation.
Clinical manifestation of antiphospholipid syndrome.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic